Independent, AI-assisted research · Affiliate disclosure
Salt Cave Finder
guide

Salt Therapy for Stress Relief: Research Quality Reviewed

By Jennifer Coleman · Wellness Journalist & Editor, Salt Cave Finder

Updated May 2026

April 12, 2026 · 16 min read

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

  • Halotherapy has shown positive effects on free-radical oxidation and local immunity in 49 patients with chronic bronchitis in a 2000 study.
  • Research on halotherapy for respiratory diseases has been published since at least 1996, with some articles appearing in 1999 and 2000.
  • While some studies suggest benefits for conditions like asthma, the Asthma and Allergy Foundation of America (AAFA) notes more research is needed.
  • Clinical trials, such as one initiated in February 2024, are still investigating the effects of halotherapy in children with asthma.

Halotherapy, often called salt therapy, involves breathing in fine salt particles in a controlled environment. While many people seek out salt rooms for general wellness and relaxation, the direct scientific research linking halotherapy specifically to stress relief is not extensively detailed in our current review of the provided sources. Instead, the bulk of the available research focuses on its effects on respiratory conditions. For example, a 2000 study on 49 patients with chronic bronchitis found that halotherapy helped correct issues with free-radical oxidation, improved local immunity, and bettered the clinical course of the disease Effectiveness of halotherapy in chronic bronchitis patients. This suggests that while direct stress relief data might be limited, improvements in respiratory health could indirectly contribute to a sense of well-being and reduced physical stress on the body. Understanding the quality and focus of existing research is key to knowing what salt therapy can and cannot claim to do. We examine the evidence to see what the data truly supports.

What is Halotherapy and How Does it Relate to Stress?

Halotherapy is a natural therapy where people breathe in microscopic salt particles. These particles are typically dispersed into a salt room or cave, creating an environment rich in dry salt aerosol. The idea is that inhaling these particles can help improve respiratory health. When we consider how this relates to stress, it is important to look at the direct evidence. Our analysis of the current research does not show direct studies on halotherapy specifically reducing psychological stress. Instead, the focus is on physical health benefits, especially for the lungs and respiratory system.

However, many people experience stress when they have ongoing health issues, particularly chronic respiratory problems. Conditions like chronic bronchitis or asthma can make daily life harder. They can cause discomfort, limit physical activity, and lead to worries about health. If a therapy can improve these respiratory conditions, it might indirectly lead to a reduction in stress. Feeling better physically often helps people feel better mentally. When someone can breathe more easily, sleeps better, or experiences fewer symptoms, their overall quality of life improves. This improvement can, in turn, lessen feelings of stress and anxiety. The concept is that by supporting the body's physical functions, halotherapy could contribute to a more relaxed state.

The research we have reviewed primarily looks at how halotherapy affects the body on a physiological level. For example, studies have investigated its impact on inflammation, immune responses, and lung function. These are all physical aspects of health. If halotherapy helps to normalize these physical processes, it could make the body more resilient. A more resilient body might be better equipped to handle stressors. For instance, if a person's immune system is stronger, they might get sick less often, which removes a common source of stress. If their breathing is clearer, they might feel less panic or discomfort related to their respiratory condition.

Salt therapy environments themselves are often designed to be calming. Salt caves typically feature dim lighting, quiet spaces, and comfortable seating. This atmosphere alone can promote relaxation. Many people find the experience of sitting in a quiet, peaceful room to be inherently stress-reducing, regardless of the direct physiological effects of the salt. This environmental factor might play a role in how people perceive the benefits of halotherapy for stress. However, to truly claim stress relief as a direct outcome of the salt particles, specific studies measuring stress hormones, psychological well-being, or anxiety levels would be needed. Without such studies, we must rely on the indirect links through improved physical health. The current body of evidence points to respiratory benefits as the primary focus, with potential secondary effects on overall well-being.

What Does Research Show for Chronic Bronchitis Patients?

Research has explored the effects of halotherapy on chronic bronchitis patients, providing specific insights into its potential benefits. A key study from 2000 looked at 49 patients who suffered from lingering inflammatory chronic bronchitis. The researchers used a chemoluminescence test to examine specific markers in the patients' blood. They found that these patients had an inhibition of active oxygen forms in their whole blood. They also noted an increase in lipid peroxidation in the serum and a weakened local immunity. These are indicators of oxidative stress and a compromised immune response, common in chronic inflammatory conditions.

The study concluded that administering halotherapy to these 49 patients led to significant improvements. Specifically, it corrected the disturbances in free-radical oxidation. This means halotherapy helped to balance the processes that can cause cellular damage due to unstable molecules. The therapy also improved local immunity, which refers to the immune system's ability to protect specific areas, like the respiratory tract, from infection and inflammation. Furthermore, the clinical course of the disease improved. This indicates that the patients experienced better overall health outcomes related to their chronic bronchitis symptoms and progression. "The chemoluminescence test in 49 patients with lingering inflammatory chronic bronchitis has revealed inhibition of generation of active oxygen forms in the whole blood, intensification of lipid peroxidation in the serum, depression of local immunity. Administration of halotherapy to the above patients results in correction of disturbances of free-radical oxidation, improves local immunity and clinical course of the disease," stated L.M. Abdrakhmanova et al. in their report Effectiveness of halotherapy in chronic bronchitis patients. This provides a concrete example of physiological changes observed after halotherapy treatment in a specific patient group.

Another study, published in 1999, also investigated halotherapy in the combined treatment of chronic bronchitis patients Halotherapy in the combined treatment of chronic bronchitis patients. While the abstract for this study does not provide specific results in English, its existence indicates a consistent interest in halotherapy as a treatment component for this condition. These studies, although some are older and published in Russian, highlight a long-standing line of inquiry into the therapeutic potential of salt therapy for chronic respiratory issues. The 2000 study, in particular, offers detailed findings on how halotherapy impacts specific biological markers and overall disease progression in chronic bronchitis.

The improvements in local immunity and the correction of free-radical oxidation disturbances are important for chronic bronchitis patients. Chronic bronchitis is characterized by inflammation and excess mucus production in the airways, often leading to persistent cough and difficulty breathing. Oxidative stress can worsen this inflammation and damage lung tissue over time. By addressing these underlying physiological issues, halotherapy could potentially reduce the severity of symptoms and improve lung function. The fact that the clinical course of the disease improved suggests a tangible benefit for patients in their daily lives. These findings point to halotherapy's potential as a supportive therapy for managing the complex symptoms of chronic bronchitis. While this research does not directly address stress relief, improving a chronic condition like bronchitis can certainly lessen the burden and worry for affected individuals, indirectly contributing to their overall well-being.

Is Halotherapy Effective for Asthma in Children?

The question of halotherapy's effectiveness for asthma, especially in children, has been a subject of scientific inquiry, with several studies and trials focusing on this area. A randomized, controlled, prospective pilot study conducted in 2016 explored halotherapy as an asthma treatment for children Halotherapy as asthma treatment in children: A randomized, controlled, prospective pilot study. This type of study design is considered robust, as it involves randomly assigning participants to either a treatment group or a control group, and it looks forward in time to observe outcomes. The "pilot" nature of the study suggests it was an initial investigation, often designed to determine feasibility and gather preliminary data for larger trials.

Following this, a randomized crossover trial in 2017 further examined the effect of salt space on clinical findings and peak expiratory flow in children with mild to moderate asthma The Effect of Salt Space on Clinical Findings and Peak Expiratory Flow in Children with Mild to Moderate Asthma: A Randomized Crossover Trial. In a crossover trial, each participant receives both the treatment and a control (or another treatment) at different times. This design allows researchers to compare the effects within the same individual, which can reduce variability. Peak expiratory flow (PEF) is a measure of how fast a person can exhale air, often used to monitor lung function in asthma patients. Observing improvements in PEF would suggest a positive impact on airway obstruction, a key feature of asthma.

The ongoing interest in this area is highlighted by a new clinical trial, NCT06250452, which began in February 2024. This study is specifically designed to investigate the effect of halotherapy in children with asthma Study Details | NCT06250452 | Effect of Halotherapy in Children With Asthma | ClinicalTrials.gov. ClinicalTrials.gov is a registry of clinical trials conducted around the world, providing details on study design, participant criteria, and outcomes being measured. The initiation of a new trial suggests that the scientific community continues to seek definitive answers regarding halotherapy's role in pediatric asthma management. Such trials are crucial for providing high-quality evidence that can inform medical practice.

While these studies suggest an ongoing exploration of halotherapy for childhood asthma, the Asthma and Allergy Foundation of America (AAFA) maintains a cautious stance, emphasizing the need for more comprehensive research. The AAFA’s perspective is discussed in detail in the next section. The combination of earlier pilot studies and ongoing clinical trials indicates a progressive effort to understand the mechanisms and clinical benefits of halotherapy for children with asthma. The fact that researchers are measuring specific clinical findings and lung function parameters like peak expiratory flow shows a commitment to evaluating concrete, measurable outcomes. These studies are critical for building a robust evidence base, which is necessary before any widespread recommendations can be made for treating a condition as serious as asthma in children. Parents considering halotherapy for their children should always consult with a pediatrician or asthma specialist to ensure it aligns with an evidence-based treatment plan.

What Do Major Health Organizations Say About Halotherapy for Asthma?

When considering any alternative therapy for a serious condition like asthma, it's important to look at the stance of major health organizations. The Asthma and Allergy Foundation of America (AAFA) is a well-recognized patient organization dedicated to improving the lives of people with asthma and allergies. The AAFA has directly addressed the topic of salt therapy, or halotherapy, and its potential role in asthma management.

The AAFA has published information to help clarify whether salt therapy is safe and effective for asthma. Their article, titled "AAFA Explains: Is Salt Therapy Safe and Effective for Asthma?", indicates that while some people may find relief from symptoms, the organization emphasizes that more research is needed to fully understand its benefits AAFA Explains: Is Salt Therapy Safe and Effective for Asthma?. This position reflects a common approach among medical and health organizations regarding therapies with limited or emerging evidence. They typically advise caution and call for more rigorous, large-scale studies before endorsing such treatments as standard care.

The AAFA's perspective is crucial because they represent a trusted source of information for patients and healthcare providers. Their emphasis on the need for more research highlights the current gaps in scientific understanding. While individual anecdotal reports or small studies might suggest benefits, these are often not sufficient to meet the high standards required for medical recommendations. For a therapy to be widely accepted and recommended by organizations like the AAFA, it typically needs to demonstrate consistent efficacy and safety across multiple well-designed clinical trials. This includes studies with large numbers of participants, appropriate control groups, and long-term follow-up.

The AAFA's statement implies that while halotherapy might be safe for some individuals, its effectiveness for asthma remains unproven to a degree that would warrant a strong endorsement. They do not dismiss the therapy outright but rather place it in a category where further investigation is essential. This aligns with the scientific process, where initial promising findings lead to more extensive research. Patients with asthma, especially children, often rely on established, evidence-based treatments to manage their condition, which can be life-threatening if not properly controlled. Therefore, any complementary therapy must be approached with careful consideration and under the guidance of a healthcare professional.

The AAFA's guidance serves as a reminder that while the concept of salt therapy for respiratory health has been explored for decades, a definitive consensus on its broad application for asthma is still developing. Their call for more research underscores the importance of ongoing clinical trials, like the one initiated in February 2024 for children with asthma, to provide the robust evidence needed for informed decisions. Until such comprehensive data is available, organizations like the AAFA will continue to advocate for caution and emphasize adherence to conventional, proven asthma treatments.

What is the General Quality of Research on Halotherapy?

The general quality of research on halotherapy, based on the provided sources, shows a consistent, though sometimes limited, effort to understand its effects, particularly on respiratory diseases. Research into halotherapy for respiratory conditions has been ongoing for many years. We see publications dating back to at least 1996, with additional articles appearing in 1999 and 2000 Halotherapy for treatment of respiratory diseases. This long history indicates that scientists have been investigating this therapy for decades, suggesting a sustained interest in its potential.

Many of the studies identified are published in specialized medical journals. For instance, the research on chronic bronchitis by L.M. Abdrakhmanova et al. appeared in "Vopr Kurortol Fizioter Lech Fiz Kult," a journal focused on balneology, physiotherapy, and exercise therapy. Another study by E.Z. Maev et al. was published in "Voen Med Zh," a military medical journal. The fact that some of these early studies are in Russian, as indicated by their PubMed entries, suggests that a significant portion of the foundational research may originate from Eastern European medical traditions where halotherapy has a longer history. This can sometimes present a challenge for broader accessibility and translation into English-language scientific discourse.

The types of studies mentioned include randomized, controlled, prospective pilot studies and randomized crossover trials. These are considered strong research designs for clinical investigations. A "randomized, controlled" study is important because it reduces bias by randomly assigning participants to groups and comparing outcomes against a control group that does not receive the treatment. A "prospective" study follows participants forward in time, observing how the treatment affects them. A "pilot study" is a smaller-scale version of a larger study, designed to test feasibility and gather preliminary data. "Crossover trials" are particularly useful as they allow each participant to serve as their own control, receiving both the treatment and a placebo or alternative treatment at different times, which can strengthen the internal validity of the findings.

Some research points to specific physiological changes, as seen in the chronic bronchitis study. That study detailed how halotherapy corrected disturbances of free-radical oxidation and improved local immunity in 49 patients Effectiveness of halotherapy in chronic bronchitis patients. Such specific findings, which measure concrete biological markers, contribute to a higher quality of evidence compared to studies relying solely on subjective patient reports. These detailed physiological analyses provide a potential mechanism of action for the therapy, explaining how it might be working at a cellular level.

However, the overall body of research, while showing promising avenues, also indicates areas for growth. The AAFA's call for "more research" on asthma, despite existing studies, suggests that the current evidence base may not yet be comprehensive enough for definitive conclusions or widespread medical endorsement. This often means that while individual studies might show positive results, there may be a need for larger sample sizes, longer follow-up periods, replication by independent research teams, or studies comparing halotherapy against established treatments. The ongoing clinical trial (NCT06250452) for children with asthma, initiated in February 2024, exemplifies this continued effort to build a stronger evidence base. The presence of such a trial on ClinicalTrials.gov, a respected global registry, indicates a move towards more transparent and rigorously designed studies.

In summary, the research quality on halotherapy appears to be varied, with some studies employing strong methodologies and identifying specific physiological impacts. There is a long history of investigation, particularly for respiratory conditions. However, the continuous call for "more research" from health organizations suggests that the cumulative evidence still requires further strengthening, particularly in the form of large-scale, definitive clinical trials, to fully establish its place in mainstream medical practice.

Are There Any Limitations to Current Halotherapy Research?

Current research on halotherapy, while demonstrating some promising areas, does have several limitations, particularly when considering its application for broader wellness benefits like stress relief. One of the most significant limitations highlighted by our review is the specific focus of the available research. The studies provided primarily concentrate on well-defined respiratory conditions such as chronic bronchitis and asthma. For instance, we see detailed findings on 49 patients with chronic bronchitis from a 2000 study Effectiveness of halotherapy in chronic bronchitis patients. We also find studies and ongoing trials related to asthma in children from 2016, 2017, and 2024 Halotherapy as asthma treatment in children: A randomized, controlled, prospective pilot study, The Effect of Salt Space on Clinical Findings and Peak Expiratory Flow in Children with Mild to Moderate Asthma: A Randomized Crossover Trial, and Study Details | NCT06250452 | Effect of Halotherapy in Children With Asthma | ClinicalTrials.gov. While these studies provide valuable insights into respiratory health, they do not directly address the topic of stress reduction.

Direct evidence linking halotherapy specifically to stress reduction is not detailed in the provided sources. This means that while people might feel less stressed after a salt therapy session, the scientific mechanisms or direct measurements of stress markers (like cortisol levels, heart rate variability, or psychological stress scales) are not presented in the research we reviewed. Any claims about stress relief from these sources would be indirect, stemming from the general improvement of a chronic physical condition, which can, in turn, reduce the stress associated with that condition. Without specific studies designed to measure stress outcomes, it is difficult to make definitive, evidence-based statements about halotherapy's direct impact on stress.

Another limitation comes from the Asthma and Allergy Foundation of America (AAFA). They explicitly suggest that more comprehensive studies are needed, especially for asthma AAFA Explains: Is Salt Therapy Safe and Effective for Asthma?. This call for "more research" indicates that existing studies, while perhaps promising, may not be robust enough in terms of sample size, duration, or replication to firmly establish halotherapy as a widely recommended treatment. Larger, multi-center trials with diverse populations and longer follow-up periods are often required to provide the high level of evidence needed for broad medical acceptance. The existence of a pilot study and subsequent crossover trial, followed by an entirely new clinical trial for asthma in children, also suggests that the evidence is still being built and refined. It points to a process where initial findings are being re-evaluated and expanded upon to achieve more conclusive results.

Furthermore, some of the foundational research is older and published in languages other than English, such as Russian. While these studies are valuable, their age and language can sometimes limit their integration into the broader English-speaking scientific community and current medical guidelines. Translating and critically evaluating these older studies in the context of modern research methodologies is an ongoing process. The lack of widely accessible, recent, large-scale studies in English specifically targeting stress relief is a notable gap for those seeking evidence on this particular benefit.

In summary, the primary limitations include a narrow focus on respiratory conditions rather than direct stress relief, the ongoing need for more comprehensive and larger-scale studies as noted by health organizations, and the historical context of some foundational research that may not fully meet modern evidentiary standards for widespread adoption. These limitations do not necessarily invalidate halotherapy's potential benefits but rather define the current boundaries of what can be confidently stated based on the available scientific evidence.

Frequently Asked Questions

Does halotherapy directly reduce stress?

Based on the research provided, direct evidence linking halotherapy specifically to stress reduction is not detailed. The studies primarily focus on respiratory conditions like chronic bronchitis and asthma. While improvements in respiratory health can indirectly lead to a reduction in stress by improving overall well-being, the provided sources do not offer direct measurements of stress markers or psychological stress outcomes.

What respiratory conditions has halotherapy been studied for?

Halotherapy has been studied for various respiratory conditions, including chronic bronchitis and asthma. A 2000 study, for example, investigated halotherapy's effects on 49 patients with lingering inflammatory chronic bronchitis, showing improvements in free-radical oxidation and local immunity Effectiveness of halotherapy in chronic bronchitis patients. Studies have also explored its use as an asthma treatment in children, with a pilot study in 2016 and an ongoing clinical trial initiated in February 2024.

Is halotherapy recognized by major health organizations for asthma?

The Asthma and Allergy Foundation of America (AAFA) has addressed halotherapy for asthma, noting that while some people may find relief, more research is needed to fully understand its benefits and effectiveness AAFA Explains: Is Salt Therapy Safe and Effective for Asthma?. This indicates that major health organizations generally maintain a cautious stance, awaiting more comprehensive and conclusive evidence before providing a strong endorsement.

How many patients were in the chronic bronchitis study that showed positive effects?

The 2000 study that revealed positive effects of halotherapy on chronic bronchitis involved 49 patients. This study found that halotherapy helped correct disturbances of free-radical oxidation, improved local immunity, and bettered the clinical course of the disease in these patients Effectiveness of halotherapy in chronic bronchitis patients.

Are there ongoing clinical trials for halotherapy?

Yes, there are ongoing clinical trials for halotherapy. For example, a study with the identifier NCT06250452, which focuses on the effect of halotherapy in children with asthma, started in February 2024 Study Details | NCT06250452 | Effect of Halotherapy in Children With Asthma | ClinicalTrials.gov. This indicates a continued scientific effort to investigate the therapeutic potential of halotherapy.

Sources

  1. https://pubmed.ncbi.nlm.nih.gov/11197648/
  2. https://pubmed.ncbi.nlm.nih.gov/10439712/
  3. https://pubmed.ncbi.nlm.nih.gov/10161255/
  4. https://pubmed.ncbi.nlm.nih.gov/27723955/
  5. https://clinicaltrials.gov/study/NCT06250452
  6. https://pubmed.ncbi.nlm.nih.gov/28732433/
  7. https://community.aafa.org/blog/aafa-explains-is-therapy-safe-and-effective-for-asthma?postsPerPage=20&sort=oldest

Related Reading

— The Salt Cave Finder Team

Find a Cave

What brings you to salt therapy?

Related Articles

Stay in the loop

Get the latest articles delivered to your inbox.